Scalar Gauge Fund founder Sumit Gautam cautious about over-hyped AI

Tech investor Sumit Gautam carefully avoids the word bubble when describing the investor frenzy surrounding the rise of artificial intelligence, but warns there are dangers of getting caught up in the hype.

Giuseppe Tauriello

Scalar Gauge Fund founder Sumit Gautam cautious about over-hyped AI

September 23, 2024
Tech investor Sumit Gautam carefully avoids the word bubble when describing the investor frenzy surrounding the rise of artificial intelligence, but warns there are dangers of getting caught up in the hype.
Read Transcript

Tech investor Sumit Gautam carefully avoids the word bubble when describing the investor frenzy surrounding the rise of artificial intelligence, but warns there are dangers of getting caught up in the hype drummed up by tech executives and venture capitalists around the emerging technology.

Tech companies leveraged to the AI boom have surged in the last couple of years, with investor groups ranging from the most sophisticated institutions to mum and dad investors pouring money in amid fears of missing out on the tech revolution.

AI poster child Nvidia’s share price has more than doubled this year alone, lifting the chip-maker's value to around $US2.8 trillion ($4.12 trillion), making it the third largest publicly traded company in the world after Apple and Microsoft.

Other tech giants, including Microsoft, Meta and Google owner Alphabet, are also riding the wave of investor demand, with double-digit share price growth since the start of the year.

While many analysts believe there is more growth to come, Gautam, who will be among the headline speakers at November’s Sohn Hearts & Minds investment conference in Adelaide, is more bearish about the ballooning valuations that have some fearing are a bubble waiting to burst.

“I would like to stay away from the word (bubble) but I would say that the pace of expectations and the amount of mind-share that AI has received in the last 18 months – it appears parabolic and capitalism does not like parabolic moves,” he says.

“I think AI is a theme, and everybody’s looking to invest in that theme. Our experience over the last decade-plus, both in the public market but before that private equity, is that investing in themes is usually not a good idea, because the way the fundamentals play out is very different than what you were investing in.

“Our experience always says that you want to invest in bottom-up evaluation of a company, and maybe the theme might help or might not help. We’re not trying to be predicting the future in any ways, but what we’re saying is that you’re better off taking things slow and letting it materialise with a relatively natural rate of growth, versus starting to have exponential growth, because exponential growth inevitably leads to crashes.”

After starting his career as a management consultant at McKinsey & Co, Gautam later worked at a tech start-up in Silicon Valley before moving into private equity at Bain and Audax Group, and later developed his tech investment specialisation while at $US1.3bn hedge fund Hirzel Capital.

In 2017 he launched Dallas-based Scalar Gauge Fund, a specialist platform that adopts a “private equity style of investing” to its holdings of predominantly US-listed software companies.

The fund has grown to around $US200m in assets under management, including a mix of passive investments and other companies where Gautam sees an opportunity to add value.

Described by some as an activist investor, Gautam prefers to focus on the “value creation” that comes with a more hands-on approach, including working closely with management to drive performance and at times pushing for board representation, as it recently has with billing software company Zuora.

“The way we think about this is as long as we are creating value, then the shareholders or the stakeholders will benefit from that value creation,” he says.

“We are focused on investing in undervalued, higher quality software companies in the public markets, but then we sometimes play a constructivist role in adding value to these companies, either just working with management, but also sometimes bringing in private equity to acquire these companies.

“So the claim to fame that we’ve had in the last seven years has been that 34 of our portfolio companies have been acquired, most of them by private equity.

“And 34 may not sound like a big number, but there’s only been about 60 public-to-private deals that have happened in this time frame in the space that we play in, in technology, so market share is more than 50 per cent.”

Indian-born Gautam studied engineering at the Indian Institute of Technology before moving to the US in the late 1990s for further studies at MIT.

He will not be drawn on his preferred candidate for the election in his adopted homeland, but says the US needs “more economic growth and we need to embrace more capitalism”.

While clearly a free marketeer, Gautam holds some concern over the rising power of the so-called Magnificent Seven tech giants.

Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta and Tesla make up around a third of the S&P 500 index, and Scalar Gauge analysis suggests that based on growth rates over the past eight years the share they could reach two-thirds within the next ­decade. “Just by the nature of that power concentration, we don’t believe that society or the laws of economics will let that happen, because it’s just not a healthy place to be,” he said.

“If that’s not the case, which means that the historical returns are not going to be the same as future returns – if you believe that assertion, then you have to look elsewhere. The capitalistic way of thinking about it is that you’ll get new companies to challenge. There’s definitely a regulation aspect to it as well.

“In general, we like government to not be involved in the markets, because it’s generally inefficient. But we also can understand the reasons, that it has impact on society, impact on free speech – these companies have become a lot more influential.

“We have nothing against these companies. And they, of course, have done phenomenally well. But we don’t believe it’s healthy on a society, or on the information dissemination viewpoint, or from just the concentration of power in just one entity.”

Gautam will be among the headline speakers at this year’s Sohn event, which has raised $70m for medical research since its launch in 2016.

Attendees will hear stock tips and investment strategies from some of the world’s top fund managers, including Oaktree Capital co-founder Howard Marks, Sydney fund manager Alex Pollak, the founder of Loftus Peak, and Terra Capital founder and chief investment officer Jeremy Bond.

The Sohn Hearts & Minds conference will be held at Adelaide’s Festival Theatre on November 15.

This article was originally posted by The Australian here. 

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on 23 September 2024. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Tech investor Sumit Gautam carefully avoids the word bubble when describing the investor frenzy surrounding the rise of artificial intelligence, but warns there are dangers of getting caught up in the hype drummed up by tech executives and venture capitalists around the emerging technology.

Tech companies leveraged to the AI boom have surged in the last couple of years, with investor groups ranging from the most sophisticated institutions to mum and dad investors pouring money in amid fears of missing out on the tech revolution.

AI poster child Nvidia’s share price has more than doubled this year alone, lifting the chip-maker's value to around $US2.8 trillion ($4.12 trillion), making it the third largest publicly traded company in the world after Apple and Microsoft.

Other tech giants, including Microsoft, Meta and Google owner Alphabet, are also riding the wave of investor demand, with double-digit share price growth since the start of the year.

While many analysts believe there is more growth to come, Gautam, who will be among the headline speakers at November’s Sohn Hearts & Minds investment conference in Adelaide, is more bearish about the ballooning valuations that have some fearing are a bubble waiting to burst.

“I would like to stay away from the word (bubble) but I would say that the pace of expectations and the amount of mind-share that AI has received in the last 18 months – it appears parabolic and capitalism does not like parabolic moves,” he says.

“I think AI is a theme, and everybody’s looking to invest in that theme. Our experience over the last decade-plus, both in the public market but before that private equity, is that investing in themes is usually not a good idea, because the way the fundamentals play out is very different than what you were investing in.

“Our experience always says that you want to invest in bottom-up evaluation of a company, and maybe the theme might help or might not help. We’re not trying to be predicting the future in any ways, but what we’re saying is that you’re better off taking things slow and letting it materialise with a relatively natural rate of growth, versus starting to have exponential growth, because exponential growth inevitably leads to crashes.”

After starting his career as a management consultant at McKinsey & Co, Gautam later worked at a tech start-up in Silicon Valley before moving into private equity at Bain and Audax Group, and later developed his tech investment specialisation while at $US1.3bn hedge fund Hirzel Capital.

In 2017 he launched Dallas-based Scalar Gauge Fund, a specialist platform that adopts a “private equity style of investing” to its holdings of predominantly US-listed software companies.

The fund has grown to around $US200m in assets under management, including a mix of passive investments and other companies where Gautam sees an opportunity to add value.

Described by some as an activist investor, Gautam prefers to focus on the “value creation” that comes with a more hands-on approach, including working closely with management to drive performance and at times pushing for board representation, as it recently has with billing software company Zuora.

“The way we think about this is as long as we are creating value, then the shareholders or the stakeholders will benefit from that value creation,” he says.

“We are focused on investing in undervalued, higher quality software companies in the public markets, but then we sometimes play a constructivist role in adding value to these companies, either just working with management, but also sometimes bringing in private equity to acquire these companies.

“So the claim to fame that we’ve had in the last seven years has been that 34 of our portfolio companies have been acquired, most of them by private equity.

“And 34 may not sound like a big number, but there’s only been about 60 public-to-private deals that have happened in this time frame in the space that we play in, in technology, so market share is more than 50 per cent.”

Indian-born Gautam studied engineering at the Indian Institute of Technology before moving to the US in the late 1990s for further studies at MIT.

He will not be drawn on his preferred candidate for the election in his adopted homeland, but says the US needs “more economic growth and we need to embrace more capitalism”.

While clearly a free marketeer, Gautam holds some concern over the rising power of the so-called Magnificent Seven tech giants.

Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta and Tesla make up around a third of the S&P 500 index, and Scalar Gauge analysis suggests that based on growth rates over the past eight years the share they could reach two-thirds within the next ­decade. “Just by the nature of that power concentration, we don’t believe that society or the laws of economics will let that happen, because it’s just not a healthy place to be,” he said.

“If that’s not the case, which means that the historical returns are not going to be the same as future returns – if you believe that assertion, then you have to look elsewhere. The capitalistic way of thinking about it is that you’ll get new companies to challenge. There’s definitely a regulation aspect to it as well.

“In general, we like government to not be involved in the markets, because it’s generally inefficient. But we also can understand the reasons, that it has impact on society, impact on free speech – these companies have become a lot more influential.

“We have nothing against these companies. And they, of course, have done phenomenally well. But we don’t believe it’s healthy on a society, or on the information dissemination viewpoint, or from just the concentration of power in just one entity.”

Gautam will be among the headline speakers at this year’s Sohn event, which has raised $70m for medical research since its launch in 2016.

Attendees will hear stock tips and investment strategies from some of the world’s top fund managers, including Oaktree Capital co-founder Howard Marks, Sydney fund manager Alex Pollak, the founder of Loftus Peak, and Terra Capital founder and chief investment officer Jeremy Bond.

The Sohn Hearts & Minds conference will be held at Adelaide’s Festival Theatre on November 15.

This article was originally posted by The Australian here. 

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on 23 September 2024. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Disclaimer: This material has been prepared by The Australian, published on Sep 23, 2024. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Ravi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn LichtRavi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn LichtRavi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn LichtRavi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn Licht
October 23, 2023

US Bank Run Has Slowed To A Walk, But Instability Remains

When Ravi Chopra reveals his stock pick at the prestigious Sohn Hearts & Minds conference at the Opera House in Sydney next month, it could well be a short bet on a US bank.

Read More
October 18, 2023

Two small caps: Propel Funeral Services (ASX: PFP) and Clarity Pharmaceuticals (ASX: CU6)

Get to know our 2023 Conference Fund Manager Rikki Bannan of IFM Investors who recently featured on the Equity Mates Media podcast.

Read More
October 16, 2023

How this hedge fund pulled off 2023’s ‘big short’

Last year, Ravi Chopra was travelling through Europe to shop his latest short idea to potential investors. “Financials are really all in the weeds,” he told The Australian Financial Review in an interview from New York.

Read More
IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.
October 10, 2023

Beware the pitfalls of investing in healthcare, says IFM boss

“Healthcare is often viewed as a stable, defensive sector to invest in, but in small caps that hasn’t necessarily proven to be the case,” she says in an interview ahead of her appearance at the Sohn Hearts & Minds Conference 2023.

Read More
October 6, 2023

Secret to a long life cheaper than you think celebrity physician Peter Attia reveals

Don't miss Dr Peter Attia who will speak at the Sohn Hearts & Minds Conference at the Sydney Opera House next month.

Read More
Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.
September 18, 2023

‘Volatility is opportunity’: why this manager loves shorting stocks

Angela Aldrich of Bayberry Capital Partners LP bet against Treasury Wine Estates at the top of the market and now she's preparing to make her next big call at this year's Sohn Hearts & Minds Conference.

Read More
September 15, 2023

Top fund managers share 11 stock picks for the long term

After a dramatic earnings season, fund managers, including Jessica Farr-Jones of Regal Funds and Kieran Moore of Munro Partners (HM1 Core Fund Managers), have shared some of their top picks for long-term growth.

Read More
September 11, 2023

Investors Sweeten On Hedge Funds As Rates Climb

After a decade of easy money pushing equity markets in one direction, Wall Street hedge fund manager Ricky Sandler says the return of volatility and higher interest rates is seeing money return to long-short strategies.

Read More
Eminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John FederEminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John FederEminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John FederEminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John Feder
September 11, 2023

Stock Stars Look Under The Surface

Influential New York-hedge fund manager Ricky Sandler returns to Australia to make a new pick at this year’s Sohn Hearts & Minds conference that will be held at the Sydney Opera House on November 17.

Read More
Barrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter Rae
September 11, 2023

Top Ny Stock Picker Warns Inflation To Remain Above Pre-Covid Levels

Influential New York hedge fund manager Ricky Sandler of Eminence Capital returns for the 2023 Sohn Hearts & Minds Conference in Sydney and says no one is focused on picking interesting, idiosyncratic stocks.

Read More
August 4, 2023

New Relic

New Relic was pitched by Ricky Sandler of Eminence Capital at the 2022 Sohn Hearts & Minds Conference.

Read More
June 18, 2023

Investors can’t agree how to value the world’s hottest stock

Despite mixed investor opinions, Munro Partners (Core Fund Manager) remains a strong believer in Nvidia. They are standing firm in their investment and still consider it a solid buy.

Read More
June 8, 2023

Stock pickers bet the field in slowing domestic market

Fund managers have batted away fears of an inflation-led recession, with Qantas, Seven Group and Treasury Wines named among the best investments by Australia’s top stock pickers.

Read More
March 27, 2023

The imaginary nepotism that drives Carsales global growth

The long-term approach of Carsales (2022 Conference stock pick) and its CEO Cameron McIntyre has delivered big gains for investors. He reveals his secret to staying strategic.

Read More
March 12, 2023

Jun Bei Liu is not giving up on the China reopening theme

Tribeca’s Jun Bei Liu says China’s reopening is only getting started, and names five ASX stocks set to benefit.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.